Assessing serum levels of SM22α as a new biomarker for patients with aortic aneurysm/dissection.
Ning ZhangYing-Ying WangHai-Juan HuGang LuXin XuYong-Qing DouWei CuiShe-Jun GaoMei HanPublished in: PloS one (2022)
Serum SM22α could be a potential predictive marker for AAD, and regulation of VSMC is a possible mechanism for the effects of SM22α.